Cutler Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Cutler Group’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,000	Closed	-$2K	–	6628
2020 Q4	$2K	Buy	+2,000	New	+$25.1K	﹤0.01%	4326
2019 Q2	–	Sell	-2,500	Closed	-$2K	–	5031
2019 Q1	$2K	Buy	+2,500	New	+$28.5K	﹤0.01%	3537
2018 Q4	–	Sell	-6,000	Closed	-$1K	–	4882
2018 Q3	$1K	Hold	6,000	–	–	﹤0.01%	3962
2018 Q2	$7K	Buy	+6,000	New	+$105K	﹤0.01%	2946
2018 Q1	–	Sell	-5,300	Closed	-$4K	–	5589
2017 Q4	$4K	Sell	5,300 -200	-4%	-$6.43K	﹤0.01%	3875
2017 Q3	$59K	Hold	5,500	–	–	﹤0.01%	2106
2017 Q2	$13K	Sell	5,500 -5,100	-48%	-$159K	﹤0.01%	3921
2017 Q1	$28K	Buy	10,600 +10,000	+1,667%	+$441K	﹤0.01%	2998
2016 Q4	$1K	Sell	600 -100	-14%	-$5.25K	﹤0.01%	6257
2016 Q3	$2K	Buy	+700	New	+$33.4K	﹤0.01%	5893
2016 Q2	–	Sell	-1,500	Closed	-$13K	–	7564
2016 Q1	$13K	Sell	1,500 -4,400	-75%	-$151K	﹤0.01%	3791
2015 Q4	$110K	Buy	+5,900	New	+$198K	0.01%	1675

Cutler Group's FPRX Position: Q2 2021 in Review

Cutler Group sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 2,200 shares — an estimated $82K sold.

Cutler Group first reported a position in FPRX in Q4 2015 and held it in 15 quarters. The position peaked at $496K in Q1 2016. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Cutler Group reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Cutler Group sold 2,200 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $82K.
Cutler Group first reported a position in Five Prime Therapeutics, Inc. in Q4 2015 and held it in 15 quarters.
Cutler Group's Five Prime Therapeutics, Inc. position peaked at $496K in Q1 2016.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.